CXCR4 and head and neck squamous cell carcinoma: Moreover, inhibition of CXCR4 via plerixafor is in clinical trials for use with advanced pancreatic, ovarian and colorectal cancers (CAM‐PLEX NCT02179970, 2014) but not in HNSCC.